“Pharmaceutical Cartridges Market Over USD 1.4 billion in 2020”, says Visiongain report

23 January 2020
Pharma

Visiongain’s new report the Pharmaceutical Cartridges Market Report 2020-2030: Forecasts by Material (Glass and Plastic) plus analysis of leading companies indicates that the global pharmaceutical cartridges market will grow at a CAGR over 6% by 2030.

It is anticipated that ongoing clinical trials to validate newly developed customized nutritional algorithms will help maintain the dominance of this regional market throughout the forecast period. In addition, a large number of facilities engaging in genetic analysis and having a well-established computer network in the U.S. have facilitated the introduction of tailored food programs. Such cartridges also require long-term storage without changing the drug's chemical formulation. It also provides a smoother line of operations as it reduces the risk of injury when medications are transported and distributed.

Prominent companies are expected to invest in the production of innovative pharmaceutical cartridges to improve the usage and use of pharmaceutical cartridges. The pharmaceutical cartridges market is divided into glass and plastic cartridges based on the type of product. The market was led by the glass group. Higher quality and resistance to harm have increased the demand for the product. It is also expected to increase the market for glass cartridges with its precise dimensional tolerances, thermal shock resistance, efficient incorporation into injection systems, and narrow cosmetic tolerances. In contrast, the glass cartridges are classified into Type 1, 2, and 3. Over the forecast period, North America is expected to experience the highest market share. Increasing prevalence of chronic diseases like arthritis and obesity is leading to market growth in North America. For example, in 2017, according to the Centers for Disease Control & Prevention (CDC), approximately 30.3 million people (9.4%) of all ages in the U.S. population suffered from diabetes and approximately 87.5% of adults suffered from obesity in 2015. These cases are expected to increase the demand for medication, especially insulin for diabetes treatment, thus fueling the growth of the market. Because of their benefits, such as long-term storage and precise dosage, drug cartridges are commonly used for insulin delivery. In addition, the increased focus of U.S. companies on the manufacture of glass cartridges will have a positive impact on the growth of the area due to their rising use in pharmaceutical packaging. Asia Pacific is expected to show the fastest growth due to the high penetration of major companies in this area as well as growing chronic disease prevalence. For example, according to the International Diabetes Federation in 2017, in the area of Southeast Asia, 82.0 million people were diagnosed with diabetes, including about 72,946,400 cases of diabetes in India. Gerresheimer AG; SCHOTT AG; West Pharmaceutical Services, Inc.; Merck KGaA; Stevanto Group; Transcoject GmbH; and Baxter International, Inc. are some of the major companies on the market. Most of these businesses have implemented strategies to improve their market position, such as new product development, the creation of new production centers and collaborations.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Global Cell Therapy Technologies market set to grow to $23bn by 2024” says new Visiongain report

Cell therapy technologies are used across various research areas including gene therapy, cancer vaccines, regenerative medicine, biologics and others. Increasing global disease burdens and the need for more personalised & precision medicine has led to massive growth in the cell technology market, which is likely to increase over the next decade.

19 February 2020

Read

“Global Asthma & COPD market set to grow to $49 bn by 2025” says new Visiongain report

The Asthma and COPD market has the potential to bring several blockbuster drugs to the marketplace due to the increasingly segmented sub-groups of patients.

17 February 2020

Read

“Global Rheumatoid Arthritis Drugs market estimated to grow at a CAGR of 0.6% in the second half of the forecast period” says Visiongain report

Another factor driving the growth in the market is the discovery of new molecules that are involved in the disease process, and hence, new strategies for treating the disease.

17 February 2020

Read

Visiongain assesses that the Contract Research Organisations (CROs) market will generate revenues of $38.0 billion in 2020

Global clinical research organizations market was valued at $34.9 billion in 2019 and is projected to grow at a CAGR of 9.5% during the forecast period 2020-2030.

12 February 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever